Net Cash Provided by (Used in) Financing Activities in USD of Corvus Pharmaceuticals, Inc. from 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2015 to Q1 2025.
  • Corvus Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $279K.
  • Corvus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $49M, a 524% increase from 2023.
  • Corvus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7.86M.
  • Corvus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $0.000, a 100% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $279K Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2023 $4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2021 $32.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2019 $1K* -$64.9M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q1 2018 $64.9M +$64.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $8K* Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03

Corvus Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $49M +$41.2M +524% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 $7.86M +$7.86M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
2022 $0 -$62.2M -100% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-25
2021 $62.2M +$60.8M +4645% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $1.31M +$1.29M +5358% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $24K -$65.2M -100% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $65.3M +$63.8M +4426% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $1.44M -$69.9M -98% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $71.4M -$23.6M -24.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $94.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.